Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4400
0.00 (0.00%)
At close: Jan 30, 2026, 4:00 PM EST
0.4563
+0.0163 (3.70%)
After-hours: Jan 30, 2026, 7:47 PM EST
MREO's stock price has decreased by -84.98% in the past year and price targets may not have had time to catch up.
Mereo BioPharma Group Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$3.90
Upside
+786.36%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $1 | Strong Buy | Reiterates | $1 | +127.27% | Jan 16, 2026 |
| Needham | Needham | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +581.82% | Jan 13, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $7 → $0.5 | Strong Buy → Hold | Downgrades | $7 → $0.5 | +13.64% | Dec 30, 2025 |
| BTIG | BTIG | Strong Buy Maintains $6 → $1 | Strong Buy | Maintains | $6 → $1 | +127.27% | Dec 29, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 29, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,036.36% | Dec 22, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +1,263.64% | Dec 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +1,718.18% | Aug 25, 2025 |
| Needham | Needham | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +1,036.36% | Jul 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,490.91% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,490.91% | Apr 9, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $7 | Buy | Initiates | $7 | +1,490.91% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,490.91% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,490.91% | Mar 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,490.91% | Jan 13, 2025 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +2,172.73% | Dec 24, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.